These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 6758119

  • 21. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
    Tomihara T, Shimazu C, Yasuda K, Kazama M, Abe T.
    Rinsho Byori; 1986 Feb; 34(2):179-84. PubMed ID: 3702087
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Antithrombin III in 86 patients with venous thrombosis (author's transl)].
    Juillet Y, Aiach M, Fiessinger JN, Leclerc M, Housset E.
    Sem Hop; 1986 Feb; 54(37-40):1126-9. PubMed ID: 217091
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Oral contraceptives and deep venous thrombosis with pulmonary embolism.
    Bouché RT, Medawar SJ, Dockery GL.
    J Foot Surg; 1982 Feb; 21(4):297-301. PubMed ID: 7186920
    [Abstract] [Full Text] [Related]

  • 26. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S, Tomita H, Yoshida M, Hori T, Igarashi C, Fujita S.
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
    Bergmann H, Blauhut B, Necek S, Kramar H, Vinazzer H.
    Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Antithrombin III in clinical practice].
    Monreal M, Rodríguez R, Monasterio I.
    Med Clin (Barc); 1980 Nov; 79(2):91-3. PubMed ID: 7121115
    [No Abstract] [Full Text] [Related]

  • 33. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL, Bick MD, Fekete LF.
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Thromboembolism. The clinical significance of antithrombin III].
    Schramm W.
    Internist (Berl); 1984 Feb; 25(2):88-92. PubMed ID: 6368458
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The clinical significance of fibrinogen degradation products.
    Bick RL.
    Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
    [No Abstract] [Full Text] [Related]

  • 38. [A case of congenital antithrombin II deficiency with pulmonary infarction].
    Terashima T, Suzuki Y, Kawai A, Yamaguchi K, Yokoyama T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Feb; 29(2):276-81. PubMed ID: 2033902
    [Abstract] [Full Text] [Related]

  • 39. [Hepatic coagulopathy--principles and therapeutic statements].
    Thaler E, Kleinberger G.
    Leber Magen Darm; 1982 Oct; 12(5):193-7. PubMed ID: 7182699
    [Abstract] [Full Text] [Related]

  • 40. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
    Schramm W.
    Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.